Insights From Global Key Opinion Leaders on Optimizing Patient Care in Gynecologic Malignances
Susana Campos, MD, MPH
Nicoletta Colombo, MD
Incorporation of guideline recommendations into the frontline care of a patient with mCRPC who is naïve to both docetaxel and novel hormone therapy
Wenxin Xu, MD
Sandy Srinivas, MD
Clinical Evidence Behind Emerging Targeted Therapy Strategies Across Gynecologic Malignances
Emerging immunotherapy combination strategies in genitourinary malignancies
Emerging targeted therapy combination strategies in genitourinary malignancies
Ignacio Duran, MD
Innovations in Oncology Learning Center From Guidelines to Practice: Gynecologic Cancer
Ritu Salani, MD, MBA
Guideline-recommended second-line treatment following an immune checkpoint inhibitor in renal cell carcinoma
Insights from global key opinion leaders on optimizing patient care in genitourinary malignancies
Recent Advances in ADT: New Insights in Advanced Prostate Cancer Treatment
Tanya Dorff, MD
Rana McKay, MD
Advancing Prostate Cancer Care: Integrating Guideline Updates and Patient Preferences for Optimal ADT Management of Advanced Prostate Cancer
Best Practices in Shared Decision-Making: Discussing ADT Regimens in mHSPC With Your Patient
Guideline-Based, Biomarker-Directed Treatment Options in Second-Line Recurrent Endometrial Cancer
Guideline Recommendations for Biomarker-Directed Therapies in Cervical Cancer
First-Line Maintenance Therapy Using PARP Inhibitors for Ovarian Cancer
Innovations in Oncology Learning Center From Guidelines to Practice: Genitourinary Cancers
Guideline Updates for ADT: Best Practices for Treating Advanced Prostate Cancer
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.